US$ 22.85
dihexa resistant to peptidases Peptide Therapy: Brain & Memory Support Dihexa vs PE-22-28: Next-Generation Nootropic
Description
miRNAs, natural compound and herbal medicines are emerging treatments of HCC which can inhibit multiple pathways including c-Met signaling pathway

Larazotide is studied for tight-junction integrity (the leaky-gut pathway), and KPV is an anti-inflammatory peptide derived from alpha-MSH

L., Peng, X., Fanning, A

Cancer 16 , 431446 (2016)
